A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment
NCT00420823
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
121
Enrollment
OTHER
Sponsor class
Conditions
Psychotic Disorders
Interventions
DRUG:
Taurine 4g
Sponsor
Melbourne Health
Collaborators
[object Object]
[object Object]